Rosemary L. Ripley - Dec 5, 2024 Form 4 Insider Report for Zevia PBC (ZVIA)

Role
Director
Signature
/s/ Lorna R. Simms, Attorney-in-Fact for Rosemary L. Ripley
Stock symbol
ZVIA
Transactions as of
Dec 5, 2024
Transactions value $
-$4,876,285
Form type
4
Date filed
12/9/2024, 07:07 PM
Previous filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVIA Class A Common Stock Sale -$4.88M -2.57M -48.56% $1.90 2.72M Dec 5, 2024 See Footnotes F2, F3, F4
holding ZVIA Class A Common Stock 153K Dec 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 118,455 RSUs. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer. 118,455 RSUs vest on the earlier to occur of (i) June 12, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders and are settled within 30 days following such vesting date.
F2 Represents securities owned directly by NGEN III, LP ("NGEN III"). Ms. Ripley directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares of Class A Common Stock owned, directly or indirectly, by NGEN III. Ms. Ripley disclaims beneficial ownership of the shares of Class A Common Stock reported herein except to the extent of her pecuniary interest therein and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 NGEN III sold 2,567,006 shares of restricted Class A Common Stock in a private block trade at a price of $1.8996 per share as determined by the 20-day Volume Weighted Average Price ("VWAP") as of the market close on December 02, 2024. The transfer was effected on or about December 5, 2024.
F4 Represents securities owned directly by NGEN Zevia SPV, LLC ("NGEN Zevia") and NGEN-Mantra Holdings LLC ("NGEN-Mantra"). Ms. Ripley directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the shares of Class A Common Stock owned, directly or indirectly, by NGEN Zevia and NGEN-Mantra. Ms. Ripley disclaims beneficial ownership of the shares of Class A Common Stock reported herein except to the extent of her pecuniary interest therein and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Of the shares of Class A Common Stock reported 2,493,594 are held by NGEN Zevia SPV, LLC and 225,664 shares are held by NGEN-Mantra Holdings LLC.